Semaglutide
aka Wegovy®, Ozempic®Once-weekly GLP-1 that helps curb appetite and slow gastric emptying.
From $199/month
See if Semaglutide fits youHow it works
Semaglutide is an incretin mimetic that activates GLP-1 receptors. It signals the pancreas to release insulin when blood sugar rises, slows how quickly the stomach empties, and reduces appetite — which together support gradual weight loss.
Appetite changes in 1–2 weeks; meaningful weight loss over 3–6 months.
Once-weekly subcutaneous injection; rotate sites (abdomen, thigh, upper arm).
Typical plan: start at 0.25 mg weekly × 4 weeks, then step up every 4 weeks (0.5 → 1.0 → 1.7 → 2.4 mg) as tolerated.
Common side effects
- Nausea, vomiting, diarrhea
- Constipation
- Stomach pain, heartburn, burping
- Headache or fatigue
Don't use if…
- Personal or family history of medullary thyroid carcinoma (MTC)
- Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
- Pregnancy or active plans to become pregnant (stop ≥2 months before)
- Prior severe allergic reaction to semaglutide
Tell your provider about…
- History of pancreatitis
- Severe gastroparesis or GI motility disorders
- Gallbladder disease
- Kidney disease
- Depression or prior suicidal ideation
Seek urgent care if you notice
FDA boxed warning
FDA boxed warning: in rodent studies, semaglutide caused thyroid C-cell tumors. Human relevance is unknown. Patients with a personal or family history of MTC or MEN 2 should not use it.